Immunocore

US · IMCR #2968 by market cap Listed 2021

29.41 -0.14 -0.47%

Live - 5344 symbols - heartbeat 495s ago · 2026-10-07 19:54

After-hours 29.41 0.00%

Market cap: 1.51B
P/E (TTM): -79.49
P/B: 3.61
EPS: -0.71
Div yield: 0.00%
52W pos: 14%

Reader sentiment Are you bullish or bearish on IMCR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing

The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
Total institutional ownership fell 0.7 percentage points.

Institutional ownership

Held by institutions: 102.11% -0.69pp
Institutions: 154 -3
As of: 2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund52.09%

Hedge Fund45.77%

VC/PE Fund1.83%

Private Company1.04%

Public Company1.02%

Government Pension Fund0.34%

Individual/Insider0.10%

Top holders as of 2026-06-30

Wellington Management Group 11.11% · 5.72M sh

RTW Investments, LP 9.46% · 4.87M sh

FMR 8.36% · 4.31M sh

PRIMECAP Management Company 7.06% · 3.64M sh

Bellevue Asset Management AG 5.41% · 2.79M sh

Tang Capital Management, LLC 5.14% · 2.65M sh

Vestal Point Capital, LP 3.50% · 1.80M sh

Two Sigma Investments, LP 3.20% · 1.65M sh

Millennium Management LLC 3.10% · 1.60M sh

Armistice Capital LLC 2.77% · 1.43M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 33 buys · 17 sells

Name	Role	Stake
Bahija Jallal	Chief Executive Officer	0.05%
John Bell	Independent Non-Executive Chairperson	0.03%
David Berman	Head of Research & Development	0.02%
Tina Leger	Chief Human Resources Officer & Director	0.00%
John Goll	SVP, Finance & Chief Accounting Officer	0.00%
Peter Ratcliffe	Independent Non-Executive Director	0.00%
Kristine Peterson	Independent Non-Executive Director	--
Roy Steven Herbst	Independent Non-Executive Director	--
Brian Di Donato	CFO & Head of Strategy	--
Baker Bros. Advisors LP	--	--

Insider transactions most recent Form 4 filings

Date	Name	Role	Type	Shares	Price
2026-05-26	John Bell	Independent Non-Executive Chairperson	Other Derivative Acquisition	+27,492	$28.52
2026-05-26	Kristine Peterson	Independent Non-Executive Director	Other Derivative Acquisition	+27,492	$28.52
2026-05-26	Roy Steven Herbst	Independent Non-Executive Director	Other Derivative Acquisition	+27,492	$28.52
2026-05-26	Peter Ratcliffe	Independent Non-Executive Director	Other Derivative Acquisition	+27,492	$28.52
2026-05-26	William Pao	Non-Executive Director	Other Derivative Acquisition	+27,492	$28.52
2026-05-26	Siddharth Kaul	Independent Non-Executive Director	Other Derivative Acquisition	+27,492	$28.52
2026-03-10	David Berman	Head of Research & Development	Intent to Sell (Form 144)	-11,832	$32.57
2026-02-17	Bahija Jallal	Chief Executive Officer	Derivative Exercise and Sale	-11,474	$32.35
2026-02-17	Bahija Jallal	Chief Executive Officer	Intent to Sell (Form 144)	-11,474	$32.35
2026-02-17	John Goll	SVP, Finance & Chief Accounting Officer	Derivative Exercise and Sale	-698	$32.35
2026-02-17	Tina Leger	Chief Human Resources Officer & Director	Derivative Exercise and Sale	-1,000	$32.35
2026-02-17	Tina Leger	Chief Human Resources Officer & Director	Intent to Sell (Form 144)	-1,000	$32.35
2026-02-17	David Berman	Head of Research & Development	Derivative Exercise and Sale	-5,965	$32.35
2026-02-17	David Berman	Head of Research & Development	Intent to Sell (Form 144)	-5,965	$32.35
2026-02-16	Bahija Jallal	Chief Executive Officer	Other Derivative Acquisition	+88,573	--
2026-02-16	Bahija Jallal	Chief Executive Officer	Other Derivative Acquisition	+395,066	$32.38
2026-02-16	Bahija Jallal	Chief Executive Officer	Derivative Exercise and Retained	+12,343	--
2026-02-16	John Goll	SVP, Finance & Chief Accounting Officer	Other Derivative Acquisition	+7,411	--
2026-02-16	John Goll	SVP, Finance & Chief Accounting Officer	Other Derivative Acquisition	+21,252	$32.38
2026-02-16	John Goll	SVP, Finance & Chief Accounting Officer	Derivative Exercise and Retained	+653	--

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.